Increasing evidence attests to strong connections between adipokines and RA pathology 31, with for instance leptin, resistin, adiponectin, and visfatin influencing RA inflammation and disease progression, which have become important therapeutic targets in RA 32. This evidence concerns the gene NAMPT and rheumatoid arthritis.